Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| naive B cell | 9 studies | 23% ± 5% | |
| endothelial cell | 7 studies | 22% ± 6% | |
| macrophage | 7 studies | 22% ± 9% | |
| capillary endothelial cell | 6 studies | 26% ± 4% | |
| memory B cell | 6 studies | 20% ± 5% | |
| endothelial cell of lymphatic vessel | 6 studies | 19% ± 3% | |
| B cell | 5 studies | 23% ± 7% | |
| CD4-positive, alpha-beta T cell | 5 studies | 22% ± 6% | |
| non-classical monocyte | 4 studies | 27% ± 11% | |
| glomerular endothelial cell | 4 studies | 62% ± 7% | |
| endothelial cell of artery | 4 studies | 22% ± 7% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 20% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of ARRDC2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 5552.58 | 653 / 653 | 100% | 65.90 | 604 / 605 |
| lung | 100% | 9329.40 | 577 / 578 | 99% | 23.92 | 1140 / 1155 |
| intestine | 100% | 3746.30 | 966 / 966 | 98% | 20.83 | 518 / 527 |
| breast | 100% | 6013.14 | 459 / 459 | 98% | 23.32 | 1098 / 1118 |
| bladder | 100% | 3768.95 | 21 / 21 | 98% | 21.67 | 492 / 504 |
| prostate | 100% | 4114.93 | 245 / 245 | 98% | 20.81 | 490 / 502 |
| uterus | 98% | 2962.24 | 166 / 170 | 98% | 25.45 | 449 / 459 |
| esophagus | 99% | 3085.43 | 1425 / 1445 | 97% | 17.41 | 177 / 183 |
| stomach | 96% | 2442.85 | 346 / 359 | 97% | 17.82 | 277 / 286 |
| kidney | 97% | 3479.15 | 86 / 89 | 96% | 47.01 | 868 / 901 |
| skin | 91% | 2417.89 | 1639 / 1809 | 97% | 17.26 | 456 / 472 |
| brain | 80% | 2151.43 | 2101 / 2642 | 98% | 31.77 | 690 / 705 |
| pancreas | 53% | 795.01 | 175 / 328 | 99% | 55.35 | 177 / 178 |
| ovary | 70% | 1288.73 | 126 / 180 | 82% | 13.16 | 354 / 430 |
| liver | 58% | 1005.59 | 132 / 226 | 91% | 46.53 | 369 / 406 |
| adrenal gland | 53% | 867.57 | 137 / 258 | 74% | 11.92 | 171 / 230 |
| adipose | 100% | 6361.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 6671.92 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 41.25 | 29 / 29 |
| spleen | 100% | 6548.30 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 38.42 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 29.89 | 1 / 1 |
| muscle | 100% | 13235.42 | 799 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 96% | 14.42 | 77 / 80 |
| peripheral blood | 94% | 3222.11 | 870 / 929 | 0% | 0 | 0 / 0 |
| heart | 92% | 2143.51 | 788 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0015031 | Biological process | protein transport |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031410 | Cellular component | cytoplasmic vesicle |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ARRDC2 |
| Protein name | Arrestin domain-containing protein 2 Arrestin domain containing 2 |
| Synonyms | PP2703 |
| Description | |
| Accessions | Q8TBH0 ENST00000593560.6 V9GYU7 ENST00000379656.7 [Q8TBH0-2] ENST00000683912.1 ENST00000222250.5 [Q8TBH0-1] ENST00000595712.6 A0A804HLL9 |